Bactrim DS Related Published Studies
Well-designed clinical trials related to Bactrim DS (Sulfamethoxazole / Trimethoprim)
Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin
infections. [2015]
Itraconazole vs. trimethoprim-sulfamethoxazole: A comparative cohort study of 200
patients with paracoccidioidomycosis. [2014]
Short- and long-term cure rates of short-duration trimethoprim-sulfamethoxazole
treatment in female dogs with uncomplicated bacterial cystitis. [2014]
Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. [2010.09]
Standard versus newer antibacterial agents in the treatment of severe acute exacerbation of chronic obstructive pulmonary disease: a randomized trial of trimethoprim-sulfamethoxazole versus ciprofloxacin. [2010.07.15]
Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. [2010.03]
Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated
skin abscesses in patients at risk for community-associated methicillin-resistant
Staphylococcus aureus infection. [2010]
Effect of long-term trimethoprim/sulfamethoxazole treatment on resistance and integron prevalence in the intestinal flora: a randomized, double-blind, placebo-controlled trial in children. [2009.05]
Ceftibuten versus trimethoprim-sulfamethoxazole for oral treatment of febrile urinary tract infection in children. [2009.03]
Trimethoprim-sulfamethoxazole in children with chronic otitis media: a randomized comparison of costs and effects. [2008.10]
A randomized trial of ceftriaxone versus trimethoprim-sulfamethoxazole to prevent ventriculoperitoneal shunt infection. [2008.04]
Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection. [2008.02.15]
Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus. [2007.07]
Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial. [2007.05]
Rapid and simultaneous determination of sulfamethoxazole and trimethoprim in human plasma by high-performance liquid chromatography. [2007.02.19]
Bioequivalence of Two Commercial Preparations of trimethoprim/sulfamethoxazole: A randomized, single-dose, single-blind, crossover trial. [2007.02]
Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. [2005.11.15]
Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. [2005.11]
Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. [2005.10.15]
Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis. [2005.10]
Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis. [2005.10]
Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. [2005.09]
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus. [2005.02]
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection. [2005.01.01]
The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283). [2004.10]
Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. [2004.02]
The effects of lincomycin-spectinomycin and sulfamethoxazole-trimethoprim on hyaluronidase activities and sperm characteristics of rams. [2003.07]
Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. [2003.03]
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. [2002.07]
Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. [2002.01.20]
Efficacy and safety of ciprofloxacin oral suspension versus trimethoprim-sulfamethoxazole oral suspension for treatment of older women with acute urinary tract infection. [2001.12]
Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. [2001.10.15]
Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease. [2001.09]
Head lice infestation: single drug versus combination therapy with one percent permethrin and trimethoprim/sulfamethoxazole. [2001.03]
Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. [2000.08.01]
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. [2000.06.06]
Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. [2000.03.22]
Measurements of reproductive function in stallions treated with trimethoprim-sulfamethoxazole and pyrimethamine. [1999.11.01]
A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) [1999.10]
Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation. [1999.10]
Trimethoprim/sulfamethoxazole does not affect the steady-state disposition of indinavir. [1999.10]
A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation. [1999.10]
A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. [1999.08]
A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group. [1999.03]
Antibiotic prophylaxis for transrectal biopsy of the prostate: a prospective randomized study of the prophylactic use of single dose oral fluoroquinolone versus trimethoprim-sulfamethoxazole. [1999]
Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem? [1999]
A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group. [1998.12.15]
Well-designed clinical trials possibly related to Bactrim DS (Sulfamethoxazole / Trimethoprim)
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an
economic evaluation alongside a randomised controlled trial. [2014]
Antibiotics for community-acquired pneumonia in children. [2013]
Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a
randomised controlled trial. [2013]
Bacteremia in human immunodeficiency virus-infected children in Cape Town, South Africa. [2011.10]
Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. [2011.07.25]
Single-dose antibiotic prophylaxis for urinary catheter removal does not reduce the risk of urinary tract infection in surgical patients: a randomized double-blind placebo-controlled trial. [2011.07]
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis. [2011.06]
Effect of nutritional status on response to treatment with artemisinin-based combination therapy in young Ugandan children with malaria. [2011.06]
Outreach education for integration of HIV/AIDS care, antiretroviral treatment, and tuberculosis care in primary care clinics in South Africa: PALSA PLUS pragmatic cluster randomised trial. [2011.04.21]
Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis. [2011.04.01]
Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ). [2011.04]
Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. [2011.03.31]
[Perioperative antibiotic prophylaxis in radical retropubic prostatectomy: a randomised pilot study of perioperative and postoperative administration]. [2011.01]
Randomised, placebo-controlled trial to evaluate co-trimoxazole to reduce
mortality and morbidity in HIV-infected post-natal women in Zambia (TOPAZ). [2011]
Unintended effects of a computerized physician order entry nearly hard-stop alert to prevent a drug interaction: a randomized controlled trial. [2010.09.27]
A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children. [2010.09.10]
Comparative study of efficacy of artesunate plus cotrimoxazole and artesunate plus chloroquine in the treatment of malaria in Nigerian children: a preliminary report. [2010.09]
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in Zambia. [2010.09]
Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind, randomized clinical trial. [2010.09]
Antibiotic therapy for Shigella dysentery. [2010.08.04]
Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. [2010.08]
Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. [2010.07.02]
A randomized controlled trial of the effect of zinc as adjuvant therapy in children 2-35 mo of age with severe or nonsevere pneumonia in Bhaktapur, Nepal. [2010.06]
Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. [2010.05]
Timing of initiation of antiretroviral drugs during tuberculosis therapy. [2010.02.25]
Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. [2010.02]
Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy
(PEG): randomised controlled trial. [2010]
A randomized controlled trial of the effect of zinc as adjuvant therapy in
children 2-35 mo of age with severe or nonsevere pneumonia in Bhaktapur, Nepal. [2010]
Treatment of toxoplasmic lymphadenitis with co-trimoxazole: double-blind,
randomized clinical trial. [2010]
Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement. [2009.12.07]
Predictors of medication adherence in an AIDS clinical trial: patient and clinician perceptions. [2009.11]
Antibiotic prophylaxis and recurrent urinary tract infection in children. [2009.10.29]
Targeting therapy to minimize antimicrobial use in preweaned calves: effects on health, growth, and treatment costs. [2009.09]
Long-term follow-up trial of oral rifampin-cotrimoxazole combination versus intravenous cloxacillin in treatment of chronic staphylococcal osteomyelitis. [2009.06]
Routine packing of simple cutaneous abscesses is painful and probably unnecessary. [2009.05]
Antibiotic prophylaxis at urinary catheter removal prevents urinary tract infections: a prospective randomized trial. [2009.04]
Antimicrobial drugs for persistent diarrhoea of unknown or non-specific cause in children under six in low and middle income countries: systematic review of randomized controlled trials. [2009.03.03]
Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children. [2009.02]
Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2-59 months of age: a multi-centric open labeled trial. [2008.12]
Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. [2008.11]
Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial. [2008.07.10]
Effects of artesunate-cotrimoxazole and amodiaquine-artesunate against asexual and sexual stages of Plasmodium falciparum malaria in Nigerian children. [2008.06]
Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. [2008.06]
18-month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Cote d'Ivoire: a cohort study. [2008.05.20]
High risk of neutropenia in HIV-infected children following treatment with artesunate plus amodiaquine for uncomplicated malaria in Uganda. [2008.04.01]
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers. [2008.04]
Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. [2008.02]
A double blind randomised placebo controlled pilot study of oral co-trimoxazole in advanced fibrotic lung disease. [2008]
Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. [2007.11.12]
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. [2007.10]
[Acute cystitis in women with type 2 diabetes. Three antimicrobial schemes] [2007.09]
Short communication: antituberculosis drug-induced hepatotoxicity is unexpectedly low in HIV-infected pulmonary tuberculosis patients in Malawi. [2007.07]
The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children. [2007.05.15]
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. [2007.03]
|
